Global Point of Care Diagnostics For Subungual Melanoma Market Research Report – Segmentation By Diagnostic Method (Dermatoscopy, Reflectance Confocal Microscopy (RCM), Sequential Dermoscopy, Total Body Photography (TBP) and Others), By End User (Dermatology Clinics, Primary Care Settings, Hospitals, Ambulatory Surgical Centers and others); Region – Size, Share, Growth Analysis |Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-16084
Format:
Region: Global
Chapter 1. GLOBAL POINT OF CARE DIAGNOSTICS FOR SUBUNGUAL MELANOMA MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Scope, Assumptions & Limitations
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. GLOBAL POINT OF CARE DIAGNOSTICS FOR SUBUNGUAL MELANOMA MARKET – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.2.1. Demand Side
2.2.2. Supply Side
2.4. Attractive Investment Propositions
2.5. COVID-19 Impact Analysis
Chapter 3. GLOBAL POINT OF CARE DIAGNOSTICS FOR SUBUNGUAL MELANOMA MARKET – Competition Scenario
3.1. Market Share Analysis & Company Benchmarking
3.2. Competitive Strategy & Development Scenario
3.3. Competitive Pricing Analysis
3.4. Supplier-Distributor Analysis
Chapter 4. GLOBAL POINT OF CARE DIAGNOSTICS FOR SUBUNGUAL MELANOMA MARKET - Entry Scenario
4.1. Regulatory Scenario
4.2. Case Studies – Key Start-ups
4.3. Customer Analysis
4.5. PESTLE Analysis
4.4. Porters Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. GLOBAL POINT OF CARE DIAGNOSTICS FOR SUBUNGUAL MELANOMA MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. GLOBAL POINT OF CARE DIAGNOSTICS FOR SUBUNGUAL MELANOMA MARKET – By Diagnostic Method
6.1. Dermatoscopy
6.2. Reflectance Confocal Microscopy (RCM)
6.3. Sequential Dermoscopy
6.4. Total Body Photography (TBP)
6.5. Others
Chapter 7. GLOBAL POINT OF CARE DIAGNOSTICS FOR SUBUNGUAL MELANOMA MARKET – By End User
7.1. Dermatology Clinics
7.2. Primary Care Settings
7.3. Hospitals
7.4. Ambulatory Surgical Centers
7.5. others
Chapter 8. GLOBAL POINT OF CARE DIAGNOSTICS FOR SUBUNGUAL MELANOMA MARKET - By Geography – Market Size, Forecast, Trends & Insights
8.1. North America
8.1.1. By Country
8.1.1.1. U.S.A.
8.1.1.2. Canada
8.1.1.3. Mexico
8.1.2. By Diagnostic Method
8.1.3. By End User
8.1.5. Countries & Segments - Market Attractiveness Analysis
8.2. Europe
8.2.1. By Country
8.2.1.1. U.K.
8.2.1.2. Germany
8.2.1.3. France
8.2.1.4. Italy
8.2.1.5. Spain
8.2.1.6. Rest of Europe
8.2.2. By Diagnostic Method
8.2.3. By End User
8.2.4. Countries & Segments - Market Attractiveness Analysis
8.3. Asia Pacific
8.3.1. By Country
8.3.1.1. China
8.3.1.2. Japan
8.3.1.3. South Korea
8.3.1.4. India
8.3.1.5. Australia & New Zealand
8.3.1.6. Rest of Asia-Pacific
8.3.2. By Diagnostic Method
8.3.3. By End User
8.3.4. Countries & Segments - Market Attractiveness Analysis
8.4. South America
8.4.1. By Country
8.4.1.1. Brazil
8.4.1.2. Argentina
8.4.1.3. Colombia
8.4.1.4. Chile
8.4.1.5. Rest of South America
8.4.2. By Diagnostic Method
8.4.3. By End User
8.4.4. Countries & Segments - Market Attractiveness Analysis
8.5. Middle East & Africa
8.5.1. By Country
8.5.1.1. United Arab Emirates (UAE)
8.5.1.2. Saudi Arabia
8.5.1.3. Qatar
8.5.1.4. Israel
8.5.1.5. South Africa
8.5.1.6. Nigeria
8.5.1.7. Kenya
8.5.1.8. Egypt
8.5.1.8. Rest of MEA
8.5.2. By Diagnostic Method
8.5.3. By End User
8.5.4. Countries & Segments - Market Attractiveness Analysis
Chapter 9. GLOBAL POINT OF CARE DIAGNOSTICS FOR SUBUNGUAL MELANOMA MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
9.1. Abbott Laboratories
9.2. Siemens Healthineers AG
9.3. Quidel Corporation
9.4. F. Hoffman-La Roche Ltd.
9.5. Danaher Corporation
9.6. Becton, Dickinson and Company
9.7. Chembio Diagnostics
9.8. EKF Diagnostics
9.9. Trinity Biotech plc
9.10. Instrumentation Laboratory (a Werfen Company)
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
The Global Point of Care Diagnostics For Subungual Melanoma Market was valued at USD 1.56 billion in 2023 and is projected to reach a market size of USD 3.24 billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 11%.
The key drivers for the Global Point of Care Diagnostics For Subungual Melanoma Market include the increasing incidence of subungual melanoma, demand for timely and convenient diagnostics, advancements in diagnostic technologies, and patient preference for non-invasive testing.
The segments under the Global Point of Care Diagnostics For Subungual Melanoma Market By End User include Dermatology Clinics, Primary Care Settings, Hospitals, Ambulatory Surgical Centers, and others.
North America is the most dominant region for the Global Point of Care Diagnostics For Subungual Melanoma Market.
The leading players in the Global Point of Care Diagnostics For Subungual Melanoma Market include Abbott Laboratories, Siemens Healthineers AG, Quidel Corporation, F. Hoffman-La Roche Ltd., Danaher Corporation, Becton, Dickinson and Company, Chembio Diagnostics, EKF Diagnostics, Trinity Biotech plc, and Instrumentation Laboratory (a Werfen Company).
